Table 1 Baseline characteristics of study participants
N = 74 | |
|---|---|
Age (years) | 53.9 ± 11.8 |
Male, n (%) | 47 (63.5) |
Duration of PD (months) | 30.0 (16.0–96.0) |
Cases of ESRD, n (%) | |
Diabetic kidney disease | 21 (28.4%) |
Hypertensive nephrosclerosis | 19 (25.7%) |
Glomerulonephritis | 17 (23.0%) |
Polycystic kidney disease | 3 (4.1%) |
aOthers | 3 (4.1%) |
Unknown | 11 (14.9%) |
Diabetes mellitus, n (%) | 21 (28.4) |
Cardiovascular disease, n (%) | 10 (13.5) |
Ever-smokers, n (%) | 29 (39.2) |
Lipid-lowering therapy, n (%) | 28 (37.8) |
Systolic blood pressure (mmHg) | 133.7 ± 21.5 |
Diastolic blood pressure (mmHg) | 75.0 ± 11.6 |
Body mass index (kg/m2) | 23.1 ± 2.8 |
Hemoglobin (g/L) | 104 ± 11 |
Glucose (mmol/L) | 5.3 ± 2.4 |
Blood urea nitrogen (mmol/L) | 7.4 ± 2.1 |
Creatinine (μmol/L) | 972.4 ± 371.3 |
Albumin (g/L) | 35 ± 5 |
Triglyceride (mmol/L) | 1.3 ± 0.8 |
Total cholesterol (mmol/L) | 4.3 ± 0.9 |
LDL cholesterol (mmol/L) | 2.4 ± 0.7 |
HDL cholesterol (mmol/L) | 1.1 ± 0.3 |
Calcium (mmol/L) | 2.2 ± 0.2 |
Phosphorous (mmol/L) | 1.7 ± 0.5 |
Total Kt/V urea (per week) | 2.1 ± 0.4 |
nPCR (g/kg/day) | 0.97 ± 0.17 |
hs-CRP (mg/L) | 0.96 (0.62–2.10) |
sST2 (ng/mL) | 75.0 ± 26.6 |
sLR11 (ng/mL) | 16.4 ± 4.8 |